Omar Khoja, Matthew Mulvey, Sarah Astill, et. al. doi: https://doi.org/10.1101/2024.07.10.24310234 Abstract Background: New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that…[...]
Read More
BY CARL HENEGHAN, 2024 PHARMA, VACCINES We’ve extracted the main points from the Kansas City Attorney General’s legal report on the case against Pfizer that we first mentioned in Due Process—all quotes are…[...]
Read More
Authored by Marina Zhang via The Epoch Times Research led by scientists at Emory University in Atlanta found that while tetanus and influenza vaccines prompt the body to produce long-lived…[...]
Read More
Stefania Campana; Claudia De Pasquale; Giacomo Sidoti Migliore;, et. al. J Immunol (2022) 209 (4): 655–659. https://doi.org/10.4049/jimmunol.2200021 Abstract Proinflammatory monocytes play a preponderant role in the development of a cytokine storm…[...]
Read More
By Colleen Doherty, MD, 2024, Medically reviewed by Renee Nilan, MD, Very Well Health COVID-19—an infection caused by the SARS-CoV-2 virus—first appeared in late 2019 and can manifest in several ways, ranging…[...]
Read More
Despite Covid-19 killing 1.2 million Americans and unleashing $18 trillion in economic damages on the US economy, the origins of the virus have yet to be officially disclosed to the American…[...]
Read More
Fatigue, brain fog and other symptoms continue to plague more than 5% of Wisconsin residents BY MEL HAMMOND , JULY 9, 2024 Autumn Bonner struggled with long COVID symptoms for a year…[...]
Read More
June 5, 2024 WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents conclusions about Long COVID diagnosis, symptoms, and impact on daily function — including that…[...]
Read More
The first strain of SARS-CoV-2, the virus that causes COVID-19, was detected in Wuhan, China in December 2019. At that time, it was called the L strain.1 Once the virus…[...]
Read More
People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer. Authors: Ewen Callaway…[...]
Read More